School of Medicine
Showing 321-340 of 579 Results
-
Zainab (Zaina) Alzawad
Clinical Assistant Professor, Emergency Medicine
BioDr. Zaina Alzawad is a clinical strategist with extensive experience advancing patient care through research, data-driven innovation, and interdisciplinary collaboration. She currently serves as a Clinical Development and Data Strategy Consultant in the Emergency Department at Stanford Health Care, where she leads and supports research and quality initiatives aimed at improving care delivery, operational efficiency, and clinical outcomes.
Dr. Alzawad’s research background is grounded in pediatric intensive care, with a growing focus on emergency care systems and innovation. She brings specialized expertise in psychometrics, quantitative and qualitative methodologies, and healthcare data analysis, supported by advanced training in measurement, statistics, and nursing science. She previously served as a Nurse Scientist at Stanford Health Care, where she led interdisciplinary studies and mentored clinical teams in research and evaluation. Driven by a passion for inquiry and impact, Dr. Alzawad actively mentors interdisciplinary teams and contributes to the design, implementation, and dissemination of studies that inform clinical practice. -
Derek F. Amanatullah, M.D., Ph.D.
Associate Professor of Orthopaedic Surgery
BioDerek F. Amanatullah, M.D., Ph.D., is a board-certified hip and knee replacement surgeon at Stanford who cares for patients with advanced arthritis, and he is frequently sought out by patients whose joint replacements become infected, unstable, or persistently painful. He has been inducted into the Hip Society, the Knee Society, and the International Knee Society, prestigious invitation-only societies for the field’s most respected joint replacement surgeons. Each recommendation he makes rests on the evidence and on the skill, preparation, and coordination of the surgical team, an approach to patients with obesity that was featured in The New York Times. He is now editing a book on that approach for Springer Nature, titled “Arthroplasty and Obesity: Expanding Access and Optimizing Outcomes.”
His laboratory showed that some joint infections persist in a dormant state that standard tests miss, and that inflammation lingering in the joint after an apparently successful treatment predicts whether the infection will return. Infection also begins with behavior in the operating room. After the Stanford Biodesign Faculty Fellowship, he used computer vision to track the motion of circulating objects during surgery, work that earned his admission as a founder to StartX (the Stanford-affiliated startup accelerator) and the 2023 HLTH Surgical Transformation Award. That same technology now lets him study the motion of people and the behaviors in the operating room that shape the safety and efficiency of surgery.
He has published more than 250 peer-reviewed papers. They have been cited more than 8,500 times. He holds 30 issued U.S. patents. He has received more than 120 honors. They include the 2025 Charles A. Engh, Sr. Excellence in Hip Research Award from Current Concepts in Joint Replacement and the Hip Society, and the 2026 Board of Specialty Societies Research Support Fund Award from the American Academy of Orthopaedic Surgeons.
He co-edits the Journal of Bone and Joint Infection. He also serves as Associate Editor for Infection at The Journal of Bone and Joint Surgery and sits on the American Academy of Orthopaedic Surgeons Committee on Devices, Biologics, and Technology. He has mentored 236 trainees and junior colleagues, taught 12 courses, and given more than 400 lectures and presentations.
He is actively seeing patients at the Stanford Joint Replacement Center in Redwood City. -
Manuel R. Amieva
Professor of Pediatrics (Infectious Diseases) and of Microbiology and Immunology
Current Research and Scholarly InterestsMy laboratory studies how bacteria colonize our bodies for long periods of time, and how interactions between bacteria and the epithelial surfaces of the gastrointestinal tract and skin may lead to disease. Epithelial surfaces are the first barrier against infection, but they also where our bodies meet and co-evolve with the microbial world.. Several of our studies have focused on the epithelial junctions as a target for bacterial pathogens. The host epithelium uses its epithelial junctions to form a tight but dynamic barrier with an external surface that is inhospitable to microbial attachment, secretes anti-microbial compounds, and has a rapid rate of self-renewal. The balance in the microbe-epithelial relationship results in silent commensalism or symbiosis; an imbalance results in diseases ranging from acute bacterial invasive disease to chronic ulcers or carcinoma.
Our laboratory has developed novel microscopy applications such as quantitative 3D confocal microscopy, electron microscopy, time-lapse imaging, microinjection and micromanipulation to visualize the interaction of pathogens with epithelial cells in culture and in animal and human tissues. Many of out studies focus on the gastric pathogen Helicobacter pylori, but we have also expanded our investigations to include the intestinal pathogens Listeria monocytogenes and Salmonella enterica, and the skin pathogen and colonizer Staphylococcus aureus. I believe that elucidating how microbes communicate with and alter our epithelial cells at a molecular level will be important for finding novel therapeutic targets to control mucosal colonization and prevent invasive disease.
Using this perspective, we have uncovered several novel concepts of how bacteria colonize and breach our epithelial surfaces. For example, we discovered that Helicobacter pylori target the intercellular junctions, and in particular that the virulence factor CagA affects junction assembly and cell polarity. This confers H. pylori the ability to extract nutrients and grow directly on the epithelial surface. We also found that these properties of CagA have consequences for cellular transformation of the epithelium. For instance, we showed that H. pylori affect the activity and state of epithelial stem cells in the stomach by colonizing the epithelial surface deep in the gastric glands. This gland-associated population is essential for pathological inflammation and hyperplasia in animal models, and confers significant colonization advantages to the bacteria. Our Listeria research uncovered a new mechanism and site where bacteria can breach the gastrointestinal epithelial barrier to invade. We found that Listeria find their receptor for invasion at sites of epithelial senescence, where the epithelial junctions undergo dynamic turnover. To study Salmonella and H. pylori we have developed a human organoid model to study their interactions with human gut epithelium in vitro. To study Staphylococcus aureus pathogenesis, we have developed methods to visualize infection at the scale of a single bacterial microcolony using an organoid culture system of human keratinocytes and fibroblasts that grow into a 3D skin-equivalent. We recently identified several proteins at the eptithelial junctions as host factors involved in the pathogenesis of one of Staphylococcus aureus major toxins. -
Antonio Amodeo
Professor of Cardiothoracic Surgery (Pediatric Cardiac Surgery)
BioAntonio Amodeo currently serves as a Professor of Pediatric Cardiac Surgery and Surgical Director of Pediatric Thoracic Organ Transplantation in the Stanford Department of Cardiothoracic Surgery at Lucile Packard Children’s Hospital Stanford. His practice encompasses pediatric cardiac surgery and thoracic organ transplantation, with a focus on advanced heart failure, ventricular assist device (VAD) therapy, myocardial recovery, and mechanical circulatory support. He also leads clinical efforts in pediatric VAD therapy and myocardial recovery, and has pioneered artificial heart therapies in children, including the world’s first permanent artificial heart implantation in a child and, at the time, the world’s smallest artificial heart implantation in the youngest patient.